Actively Recruiting
Predictive Factors for Treatment Response in Patients With Newly-diagnosed Polymyalgia Rheumatica and Giant Cell Arteritis
Led by University Hospital, Basel, Switzerland · Updated on 2025-04-01
30
Participants Needed
1
Research Sites
339 weeks
Total Duration
On this page
Sponsors
U
University Hospital, Basel, Switzerland
Lead Sponsor
S
Schweizerische Stiftung für die Erforschung der Muskelkrankheiten
Collaborating Sponsor
AI-Summary
What this Trial Is About
This prospective study is to explore different predictive factors for response to steroid treatment in patients with PMR and/or GCA. It evaluates the association of endogenous GC suppression (plasma and urinary cortisol and cortisone) to the responsiveness of PMR/GCA to GCs.
CONDITIONS
Official Title
Predictive Factors for Treatment Response in Patients With Newly-diagnosed Polymyalgia Rheumatica and Giant Cell Arteritis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients diagnosed with polymyalgia rheumatica using the 2012 provisional classification criteria or giant cell arteritis according to published criteria
- Consent to participate in the SCQM database
- Treatment following standardized treatment protocols for PMR and GCA
You will not qualify if you...
- Currently treated with Tocilizumab, methotrexate (MTX), or other disease-modifying medications at the time of inclusion
- History of polymyalgia rheumatica or giant cell arteritis in the past
- Unable to provide informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Department of Rheumatology University Hospital Basel
Basel, Switzerland, 4031
Actively Recruiting
Research Team
T
Thomas Daikeler, Prof. Dr. med.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here